N/A
N=769
Early Discharge After Primary Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction
Bottom Line
View on ClinicalTrials.gov: NCT01860079 ↗Enrolled (actual)
769
Serious AEs
6.0%
Results posted
Apr 2016
Primary outcome: Primary: All Cause Mortality and Readmission at 30 Days. — 16; 28 participants — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- early discharge (Procedure)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Acibadem University
- Primary completion
- May 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY All Cause Mortality and Readmission at 30 Days. |
16; 28 | <0.05 sig |
Summary
* When Primary percutaneous coronary intervention (PPCI) is performed expeditiously and at a high-volume centre, it is the optimal approach for ST elevation myocardial infarction (STEMI) . In contrast to the clarity of how to treat STEMI, there is no clear definition for when to discharge and which patient to discharge.
* An early discharge strategy may be desired by all parties (financial health care provider, treating physician, nurse, patient, patient's relatives)involved in STEMI.
* The main goal in our study is to test the hypothesis that an early discharge strategy within 48-56 hours in patients with successful PPCI is as safe as in those patients who stay longer (96-120 hours) as of a standard procedure.
Eligibility Criteria
Inclusion Criteria
- Signed informed consent and subsequent written agreement of a family member (confirming good social background)
- Acute STEMI, defined as >30 minutes of continuous typical chest pain and ST-segment elevation ≥2 mm in two contiguous electrocardiography leads and /or left bundle branch block within 12 hours of symptom onset.
- Haemodynamically stable Angiographically
- Successful PPCI procedure (TIMI 2-3 flow and % 6 hours after PPCI.
Data sourced from ClinicalTrials.gov (NCT01860079). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.